PI3K-delta has 16 programs in drug discovery and preclinical today, despite half-a-dozen in the clinic already.
FORBES: Immunokinase Drug Candidates: $12B in Value Creation and Counting
The final study looked at a new class of drugs called PI3K delta inhibitors, being tested in patients with chronic lymphocytic leukemia.
CNN: A workout a day may keep cancer away
应用推荐
模块上移
模块下移
不移动